HIV Pre-Exposure Prophylaxis (PrEP)
Guidelines for PrEP to prevent HIV acquisition.
Reviewed by Dr Kola Tytler MBBS CertHE MBA MSt MRCGP (General Practitioner)
Last reviewed: 21 October 2025
regional clinical guidance
HIV Pre-Exposure Prophylaxis (PrEP): guidance by region
Recommendations, thresholds and pathways can differ. Open the page written for the jurisdiction you need.
United StatesHIV preexposure prophylaxisPublic health Β· reviewed 2026-08-20CanadaHIV PrEP: eligibility, dosing options, baseline tests, and monitoringPublic health Β· reviewed 2026-08-20AustraliaHIV PrEP: eligibility, dosing options, baseline tests, and monitoringPublic health Β· reviewed 2026-08-20
Clinical Guidelines
NICE CKS: HIV infection and AIDS
National
NICE guideline NG221: HIV testing and preventionNational
ACOG Practice Advisory: Preexposure Prophylaxis for the Prevention of Human Immunodeficiency VirusLocal
BASHH/BHIVA guidelines on the use of HIV pre-exposure prophylaxis (PrEP) 2025Local
Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxisLocal
CDC Clinical Practice Guideline: Preexposure Prophylaxis for the Prevention of HIV Infection in the United States β 2021 UpdateLocal
Guidance on the use of HIV Pre-exposure Prophylaxis (PrEP) in Hong KongLocal
HIV Prevention Guidelines on Pre-Exposure Prophylaxis (PrEP) | NIHLocal
Pre-exposure Prophylaxis (PrEP) to Prevent HIV During Perinatal Exposure: Clinical GuidelinesLocal